Acorah Software Products - Accounts Production 16.3.350 false true false true No description of principal activity 1 August 2023 31 August 2024 31 August 2024 15043216 Mr Hammaad Shafiq iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15043216 2023-07-31 15043216 2024-08-31 15043216 2023-08-01 2024-08-31 15043216 frs-core:CurrentFinancialInstruments 2024-08-31 15043216 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-08-31 15043216 frs-bus:FilletedAccounts 2023-08-01 2024-08-31 15043216 frs-bus:Micro-entities 2023-08-01 2024-08-31 15043216 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-08-31 15043216 frs-bus:Director1 2023-08-01 2024-08-31
Registered number: 15043216
Shafiqpharma Ltd
Unaudited Financial Statements
For the Period 1 August 2023 to 31 August 2024
A Patel & Co Accountants
Licensed by AAT - Reg. No. 1199
341 Derby Street
Bolton
BL3 6LR
Balance Sheet
Registered number: 15043216
31 August 2024
£
Current assets 5,060
Creditors: Amounts Falling Due Within One Year (4,091 )
NET CURRENT ASSETS 969
TOTAL ASSETS LESS CURRENT LIABILITIES 969
Accruals and deferred income (858 )
NET ASSETS 111
CAPITAL AND RESERVES 111

Notes

1. General Information
Shafiqpharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15043216 . The registered office is 185 Bury Road, Bolton, Greater Manchester, BL2 6AD.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Hammaad Shafiq
Director
22/01/2025